App-Quantinova.ai

Aldosterone and Mineralocorticoid Receptor as Inducers of Immune Markers in Peripheral Blood Mononuclear Cells: Beyond Elevating Blood Pressure

Andrea Vecchiola - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Soluble CD163, A Circulating Marker of Macrophage Activation, Associates With a Less Favourable Metabolic Profile in Children

Gemma Carreras-Badosa - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Cortisol:Cortisone Ratio and Metalloproteinase 9 Emerging as Risk Factors Associated with Paediatrics Hypertension

Alejandro Martinez-Aguayo - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Higher Urinary Iodine Levels Iodine Correlates with Lower Systolic Blood Pressure in Chilean Schoolchildren

Francisca Grob - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Microalbuminuria

N/A

Waist Height Ratio as a Marker of Obesity and Insulin Resistance in Adolescents

V Sri Nagesh - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Decrease of Small Dense LDL and Lipoprotein-Associated Phospholipase A2 due to Human GH Treatment in Short Children with GH Deficiency and Small for Gestational Age Status

Andreas Krebs - European Society for Paediatric Endocrinology (ESPE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Cardiovascular risk factors in patients with medically observed and operated primary hyperparathyroidism

Berna Imge Aydogan - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Primary hyperparathyroidism

Ergocalciferol

The effect of oxidative stress to cardiovascular risk profile among non-functional adrenal incidentaloma patients

Kamile Gul - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Adrenal carcinoma

Superoxide dismutase

Increased circulating urocortin-3 levels is associated with polycystic ovary syndrome

Ozgur Yilmaz - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

N/A

Relationship between polycystic ovary syndrome and platelet distribution width

Muzaffer Temur - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

N/A

The evaluation of oxidative status via the measurements of total oxidant status, total anti-oxidant status, ischaemia-modified albumin and oxidised-low density lipoprotein in patients with vitamin D deficiency

Ummugulsum Can - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vitamin D deficiency

Fibrinogen (IV)

Insulin receptor substrate 1 and 2 genes polymorphisms are associated with metabolic syndrome but not cardiovascular risk factors in patients with metabolic syndrome

Sefa Sarac - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Metabolic syndrome

Fibrinogen (IV)

Optimal glycaemic control and a low rate of micro and macrovascular complications in patients with HNF1AMODY treated in a dedicated tertiary referral centre

Siobhán Bacon - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Peripheral artery disease

N/A

Weight loss with bariatric surgery improves ischaemia modified albumin levels and oxidative status in morbidly obese patients

Muzaffer Ilhan - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

The risk of future IRS among women with history of gestational diabetes

Sevda Ozel Yildiz - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Metabolic syndrome

Interleukin

C-reactive protein assay in obese paediatric patients: comparison of two laboratory methods

Marta Manacas - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Cardiovascular risk factors and metabolic parameters in GH deficient patients

Sideris P Delaroudis - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Thrombomodulin alfa

The effect of gonadotropin treatment on insulin resistance and cardiovascular risk factors in patients with idiopathic hypogonadotropic hypogonadism

Kenan Guclu - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypogonadotropic hypogonadism 7 with or without anosmia

N/A

Cushing-s disease: reversibility of glucose homeostasis alterations and improvement in insulin resistance indices following a successful, transsphenoidal surgery

Przemyslaw Witek - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Cushing's syndrome

Fibrinogen (IV)

The association between sick euthyroid syndrome and hs-CRP in obese patients without comorbidities

Tayyibe Saler - European Congress of Endocrinology (ECE) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Filters

1408 Abstracts